Vaccinations in disease models with antibody-dependent enhancement

Mathematical Biosciences

Volumn 211, Issue 2, 2008, Pages 265-281

  Billings, Lora ^a   Fiorillo, Amy ^a   Schwartz, Ira B ^b  

^a MONTCLAIR STATE UNIVERSITY   (United States)

^b NAVAL RESEARCH LABORATORY   (United States)

Author keywords

Antibody dependent enhancement; Epidemics; Vaccine

Indexed keywords

DISEASES; EPIDEMIOLOGY; VACCINES; VIRUSES;

ANTIBODY-DEPENDENT ENHANCEMENT; CHAOTIC DESYNCHRONIZATION; EPIDEMIC MULTISTRAIN MODEL;

ANTIBODIES;

ANTIBODY; DISEASE SPREAD; NUMERICAL MODEL; VACCINATION; VIRAL DISEASE;

ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; DISEASE MODEL; MATHEMATICAL MODEL; VACCINATION; VIRUS STRAIN;

ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE; DENGUE VACCINES; DENGUE VIRUS; MODELS, IMMUNOLOGICAL; VACCINATION;

EID: 38349011089     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2007.08.004     Document Type: Article

References (19)

1. Billings L., Schwartz I.B., Shaw L.B., Burke D.S., and Cummings D.A.T. Instabilities in multiserotype disease models with antibody-dependent enhancement. J. Theor. Biol. 246 (2007) 18
2. Castillo-Chavez C., Hethcote H.W., Andreasen V., Levin S.A., and Liu W.M. Epidemiological models with age structure, proportionate mixing, and cross-immunity. J. Math. Biol. 27 (1989) 233
3. D.A.T. Cummings, Doctoral Thesis, Johns Hopkins University, 2004.
4. Cummings D.A.T., Schwartz I.B., Billings L., Shaw L.B., and Burke D.S. Dynamic effects of antibody dependent enhancement on the fitness of viruses. Proc. Natl. Acad. Sci. USA 102 (2005) 15259
5. Esteva L., and Vargas C. Coexistence of different serotypes of dengue virus. J. Math. Biol. 46 (2003) 31
6. Ferguson N., Anderson R., and Gupta S. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc. Natl. Acad. Sci. USA 96 (1999) 790
7. Ferguson N.M., Donnelly C.A., and Anderson R.M. Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. Phil. Trans. R. Soc. London Ser. B 354 (1999) 757
8. Center for Disease Control website, 2006. .
9. Center for Disease Control website, 2006. .
10. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 10 (2002) 100
11. Gubler D.J., Kuno G., Sather G.E., and Waterman S.H. A case of natural concurrent human infection with two dengue viruses. Am. J. Trop. Med. Hyg. 34 (1985) 170
12. Halstead S.B., and Deen J. The future of dengue vaccines. The Lancet 360 (2002) 1243
13. Halstead S.B., Heinz F.X., Barrett A.D.T., and Roehrig J.T. Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 june 2003, vienna, austria. Vaccine 23 (2005) 849
14. I.B. Schwartz, L.B. Shaw, D.A.T. Cummings, L. Billings, M. McCrary, D. Burke, Chaotic desynchronization of multi-strain diseases, Phys. Rev. E, 72:art. no. 066201, 2005.
15. Shaw L.B., Billings L., and Schwartz I.B. Using dimension reduction to improve outbreak predictability of multistrain diseases. J. Math. Biol. 55 (2007) 1
16. van den Driessche P., and Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180 (2002) 29
17. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsaakulrach B., Rothman A.L., Ennis F.A., and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181 (2000) 2
18. World Health Organization website, 2006, .
19. World Health Organization website, 2006, Section520-2417.htm .